1. Ventura A, Massei F, Not T, et al.Systemic Bartonella infection with hepatosplenic involvement.J Pediatr Gas troenterol Nutr1999;29:52-56.
2.
2. Sanchez MA, Garrido CS, Whitfeld MJ, et al. Molecular epidemiology of Bartonella infections in patients with bacillary angiomatosis-peliosis. NEJM. 1997;337: 1876-1883.
3.
3. Bass JW, Vincent JM, Person DA. The expanding spectrum of Bartonella infections: II. Cat-scratch disease. Pediatr Infect Dis J. 1997;16:163-179.
4.
4. Adams WC, Hindmann SM. Catscratch disease associated with osteolytic lesion.J Pediatr1954;44:665-669.
5.
5. Carithers HA. Cat-scratch disease with an osteolytic lesion. Am J Dis Child. 1983:968-970.
6.
6. Robson JM, Harte GJ, Osborne DR, Mc Cormack JG. Cat-scratch disease with paravertebral mass and osteomyelitis. Clin Infect Dis. 1999;28: 274-278.
7.
7. Hulzebos CV, Koetse HA, Kimpen JL, Wolfs TF. Vertebral osteomyelitis associated with cat-scrach disease. Clin Infect Dis. 1999;28:1310-1312.
8.
8. Modi SP, Eppes SC, Klein JD. Catscratch disease presenting as multifocal osteomyelitis with thoracic abscess. Pediatr Infect Disj2001;20:1006-1007.
9.
9. Not T, Canciani M, Buratti E, et al. Serologic response to Bartonella henselae in patients with cat scratch disease in sick and healthy children. Acta Pediatrica. 1999;88:284-289.
10.
10. Bass JW, Freitas BC, Freitas AD, et al. Prospective randomized double-blind placebo-controlled evaluation of azithromycin for treatment of cat scratch disease. Pediatr Infect Dis J. 1998; 17:447-452.